Provider: View Press Release
Type: Link
Title: Press Release: Sanofi completes acquisition of Provention Bio, Inc.
Description: Sanofi completes acquisition of Provention Bio, Inc. Paris, April 27 2023. Sanofi announced today the completion of its acquisition of Provention...
Provider: View Press Release
Type: Link
Title: Press Release: Strong Q1 growth driven by Specialty Care, Vaccines and CHC
Description: Strong Q1 growth driven by Specialty Care, Vaccines and CHC Paris, April 27, 2023 Q1 2023 sales growth of 5.5% at CER and business EPS(1) growth of...
Provider: View Press Release
Type: Link
Title: Press Release: Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention Bio, Inc.
Description: Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention Bio, Inc. Paris, France – April 26, 2023 – Sanofi announced today that the...
Provider: View Press Release
Type: Link
Title: Press Release: Elisabeth Moreno to join Sanofi's Diversity, Equity and Inclusion Board
Description: Elisabeth Moreno to join Sanofi's Diversity, Equity and Inclusion Board Paris, April 17, 2023. Sanofi announces the appointment of Elisabeth...
Provider: View Press Release
Type: Link
Title: Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements
Description: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Modification of existing collaboration agreement with AstraZeneca gives Sanofi...
Provider: View Press Release
Type: Link
Title: Media Update: New late-breaking data at ATS 2023 demonstrate significant advancements across Dupixent® and broader respiratory pipeline
Description: New late-breaking data at ATS 2023 demonstrate significant advancements across Dupixent® and broader respiratory pipeline 17 abstracts showcase new...